Insights 8 9 6 2 3 4 5 In late March, the Stanford Center for Digital Health convened a workshop of clinicians, researchers, tech developers, and industry stakeholders, to explore "how digital tools, artificial intelligence, and lifestyle interventions can support a more holistic and patient-centered approach to metabolic health for individuals using GLP-1 therapies." This is the report that came out of that workshop.
Chen, S., Okahara, F., Osaki, N
Comprehensive Care Options: Benefit from a diverse range of supportive therapies including custom peptide protocols, nutrient IV therapy, and professional hormone optimization
It is worth noting that GLP-1 receptor agonists show neutral effects on heart failure hospitalisation, unlike SGLT2 inhibitors which demonstrate benefit in this area
Finley says she still had to put in a lot of work to get healthy
Put on your nitrile gloves